Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 86

1.

Diagnostic and prognostic morphometric features in WHO2003 invasive endometrial stromal tumours.

Feng W, Malpica A, Yinhua Y, Janssen E, Gudlaugsson E, Zhou X, Baak JP.

Histopathology. 2013 Apr;62(5):688-94. doi: 10.1111/j.1365-2559.2011.04120.x.

PMID:
23530584
2.

Prognostic value of the diagnostic criteria distinguishing endometrial stromal sarcoma, low grade from undifferentiated endometrial sarcoma, 2 entities within the invasive endometrial stromal neoplasia family.

Feng W, Malpica A, Robboy SJ, Gudlaugsson E, Hua K, Zhou X, Baak JP.

Int J Gynecol Pathol. 2013 May;32(3):299-306. doi: 10.1097/PGP.0b013e318229adfb.

PMID:
23545579
3.

Prognostic indicators in WHO 2003 low-grade endometrial stromal sarcoma.

Feng W, Hua K, Gudlaugsson E, Yu Y, Zhou X, Baak JP.

Histopathology. 2013 Apr;62(5):675-87. doi: 10.1111/j.1365-2559.2011.04115.x. Epub 2013 Feb 21.

PMID:
23425310
4.

Renal epithelioid angiomyolipoma with atypia: a series of 40 cases with emphasis on clinicopathologic prognostic indicators of malignancy.

Brimo F, Robinson B, Guo C, Zhou M, Latour M, Epstein JI.

Am J Surg Pathol. 2010 May;34(5):715-22. doi: 10.1097/PAS.0b013e3181d90370.

PMID:
20410812
5.

Can proliferation biomarkers reliably predict recurrence in World Health Organization 2003 defined endometrial stromal sarcoma, low grade?

Feng W, Malpica A, Skaland I, Gudlaugsson E, Robboy SJ, Dalen I, Hua K, Zhou X, Baak JP.

PLoS One. 2013 Oct 11;8(10):e75899. doi: 10.1371/journal.pone.0075899. eCollection 2013.

6.

Nuclear size, shape, and density in endometrial carcinoma: relationship to survival at over 5 years of follow-up. Does analyzing only cells occupying the G0-G1 peak add useful information?

Miller J, Geisler JP, Manahan KJ, Geisler HE, Miller GA, Zhou Z, Wiemann MC, Crabtree W.

Int J Gynecol Cancer. 2004 Jan-Feb;14(1):138-44.

PMID:
14764042
7.

Prognostic impact of morphometric nuclear grade of endometrial carcinoma.

Salvesen HB, Iversen OE, Akslen LA.

Cancer. 1998 Sep 1;83(5):956-64.

PMID:
9731900
8.

Stages I to II WHO 2003-defined low-grade endometrial stromal sarcoma: how much primary therapy is needed and how little is enough?

Feng W, Hua K, Malpica A, Zhou X, Baak JP.

Int J Gynecol Cancer. 2013 Mar;23(3):488-93. doi: 10.1097/IGC.0b013e318247aa14.

PMID:
23435438
9.

Outcome and prognostic factors in endometrial stromal tumors: a Rare Cancer Network study.

Schick U, Bolukbasi Y, Thariat J, Abdah-Bortnyak R, Kuten A, Igdem S, Caglar H, Ozsaran Z, Lössl K, Schleicher U, Zwahlen D, Villette S, Vees H.

Int J Radiat Oncol Biol Phys. 2012 Apr 1;82(5):e757-63. doi: 10.1016/j.ijrobp.2011.11.005. Epub 2012 Jan 31.

PMID:
22300565
10.

Low-grade endometrial stromal sarcoma and undifferentiated endometrial sarcoma: a comparative analysis emphasizing the importance of distinguishing between these two groups.

Bartosch C, Exposito MI, Lopes JM.

Int J Surg Pathol. 2010 Aug;18(4):286-91. doi: 10.1177/1066896909337600. Epub 2009 May 29.

PMID:
19482859
11.
12.

The impact of tumor morcellation during surgery on the outcomes of patients with apparently early low-grade endometrial stromal sarcoma of the uterus.

Park JY, Kim DY, Kim JH, Kim YM, Kim YT, Nam JH.

Ann Surg Oncol. 2011 Nov;18(12):3453-61. doi: 10.1245/s10434-011-1751-y. Epub 2011 May 4.

PMID:
21541824
13.

Description of a novel system for grading of endometrial carcinoma and comparison with existing grading systems.

Alkushi A, Abdul-Rahman ZH, Lim P, Schulzer M, Coldman A, Kalloger SE, Miller D, Gilks CB.

Am J Surg Pathol. 2005 Mar;29(3):295-304.

PMID:
15725797
14.

Endometrial stromal sarcomas: a review of potential prognostic factors.

Chew I, Oliva E.

Adv Anat Pathol. 2010 Mar;17(2):113-21. doi: 10.1097/PAP.0b013e3181cfb7c2. Review.

PMID:
20179433
15.
16.

A well circumscribed uterine endometrial stromal tumor with smooth muscle differentiation recurred as a low grade endometrial stromal sarcoma: is tumor margin enough for the diagnosis?

Song JS, Lee SR, Kim KR.

Pathol Int. 2012 May;62(5):363-5. doi: 10.1111/j.1440-1827.2012.02801.x. No abstract available.

PMID:
22524669
17.

Comparison of classic and quantitative prognostic factors in colorectal cancer.

Ropponen K, Eskelinen M, Kosma VM, Lipponen P, Paakkinen P, Alhava E.

Anticancer Res. 1996 Nov-Dec;16(6B):3875-82.

PMID:
9042274
18.
19.

Nuclear features in endometrial cytology: comparison of endometrial glandular and stromal breakdown and endometrioid adenocarcinoma grade 1.

Norimatsu Y, Shigematsu Y, Sakamoto S, Ohsaki H, Yanoh K, Kawanishi N, Kobayashi TK.

Diagn Cytopathol. 2012 Dec;40(12):1077-82. doi: 10.1002/dc.21738. Epub 2012 Jan 12.

PMID:
22241733
20.

Diagnostic use of nuclear beta-catenin expression for the assessment of endometrial stromal tumors.

Jung CK, Jung JH, Lee A, Lee YS, Choi YJ, Yoon SK, Lee KY.

Mod Pathol. 2008 Jun;21(6):756-63. doi: 10.1038/modpathol.2008.53. Epub 2008 Mar 28.

Supplemental Content

Support Center